Definitive Contract N6893622C0040
Award Date
9/30/22
Potential Completion Date
6/30/23
Potential Value
$254K
Federal Agency
Naval Air Warfare Center
Awardee
Amyris, Inc.
Ultimate Awardee
Not listed
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Oakland, CA 94608, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $348,491.06 firm-fixed price definitive contract awarded by the Department of the Navy's Naval Air Systems Command to Cambium Biomaterials Inc., a for-profit manufacturer, to fabricate and test biosynthetic composite materials in support of an Office of Naval Research program. The contract has a performance period of five years, with a completion date of December 16, 2022. The work involves resin synthesis, carbon fiber composite fabrication, drone airframe assembly and testing to...
This is a $1,699,977.85 firm-fixed-price Definitive Contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Pearl Bio, Inc., a small business. The contract is for the STTR Phase II project "Scalable Production of Sequence-Defined Biopolymers Containing Multiple Distinct Non-Canonical Amino Acids in Recoded Cell and Cell-Free Systems." This builds upon a previous STTR Phase I contract awarded to Pearl Bio in 2023. The project aims to enhance...
This federal contract award is for the CRUDE PEPTIDE SYNTHESIS, with a potential value of $22,593.00. The contract was awarded to A & A Labs LLC, doing business as Synthetic Biomolecules, a minority-owned, self-certified small disadvantaged business, and limited liability company. The contract is a purchase order with a firm fixed price, awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases. The place of...
This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
This federal contract award, valued at $94,660.63, was issued by the National Institutes of Health (NIH) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 13, 2020. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
<p>This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Biovision Inc., a small disadvantaged business, on April 24, 2015. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a ceiling value of $95,640.25 and a completion date of July 25, 2015. The contract does not have a set-aside designation.</p>
This is a firm fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services (HHS), to American Biochemicals Inc. The contract is for the provision of 1 gram of ML246 (metarrestin) compound for $86,000.00. The contract does not have a set-aside designation. American Biochemicals Inc. is a minority-owned, small disadvantaged business that specializes in small molecule design, optimization,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of pharmaceutical products, including the drug Humira, to the U.S. government. The contract has a ceiling value of $11,808.63 and is a Firm Fixed Price Delivery Order with a period of performance through May 6, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, valued...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The contract, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a ceiling value of $25,656.54 and a completion date of September 3, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...
This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order has a ceiling value of $1,306.03 and an ultimate completion date of April 17, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...